Correlating these engraftment kinetics with BALF turbidity as a critical marker of disease severity ( Figure 6C and D ), the occurrence of the Siglec-F + CD11c-“AM progenitor-like” population two weeks after HSCT was associated with a small, though not yet significant, improvement.
← all excerpts
Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis.
1
—
—